Bright Peak Therapeutics
Signal active
Organization
Contact Information
Overview
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. The company's immunotherapies allow tissue and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy.
About
Industries
Biotechnology, Life Science, Medical, Therapeutics
Founded
2017
Employees
51-100
Headquarters locations
Switzerland, Europe
Social
N/A
Profile Resume
Bright Peak Therapeutics headquartered in Switzerland, Europe, operates in the Biotechnology, Life Science, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $11.1B in funding across 48 round(s). With a team of 51-100 employees, Bright Peak Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Bright Peak Therapeutics, raised $90.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
10
Lead Investors
0
Total Funding Amount
$232.0M
Details
3
Bright Peak Therapeutics has raised a total of $232.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 35.0M | ||
| 2021 | Early Stage Venture | 107.0M | ||
| 2024 | Late Stage Venture | 90.0M |
Investors
Bright Peak Therapeutics is funded by 31 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Alexander Mayweg | - | FUNDING ROUND - Alexander Mayweg | 90.0M |
| Tom Woiwode | - | FUNDING ROUND - Tom Woiwode | 90.0M |
| Bright Peak Therapeutics | - | FUNDING ROUND - Bright Peak Therapeutics | 90.0M |
| Versant Ventures | - | FUNDING ROUND - Versant Ventures | 90.0M |
Recent Activity
There is no recent news or activity for this profile.